Quest Diagnostics ( $DGX) and the Case for a $260 Price Target (Check any stock’s price target on Tickeron.) The selected price target is $260 per share, roughly 10% above Quest Diagnostics' recent close near $236. The strongest bullish factors include solid organic revenue growth, expansion in high-value advanced diagnostics, and an active acquisition strategy. The biggest risks are potential reimbursement pressure, a richer valuation, and execution risk tied to M&A integration. $LH $SYK $MDT $ABT $SNN
published
Quest Diagnostics ( $DGX) and the Case for a $260 Price Target (Check any stock’s price target on Tickeron.) The selected price target is $260 per share, roughly 10% above Quest Diagnostics' recent close near $236. The strongest bullish factors include solid o
$DGX$LH$SYK$MDT$ABT$SNN
Latest documented BWB result
See Billy's timestamped results and follow-through.
Review the latest gains posts, original timestamps, and proof images published by Banking With Billy.
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.
